KENTA BIOTECH
Kenta Biotech is focusing on the discovery and development of innovative, fully human monoclonal antibodies for the life-saving treatment of patients with serious infectious diseases. For the discovery of their monoclonal antibodies, they are using their proprietary MabIgX technology platform that enables the generation of an advanced class of fully human monoclonal antibodies that are expected to have superior safety and efficacy profiles.
KENTA BIOTECH
Social Links:
Industry:
Biotechnology Medical
Founded:
2006-01-01
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.kentabiotech.com
Total Employee:
11+
Status:
Active
Contact:
41 58 680 52 52
Email Addresses:
[email protected]
Total Funding:
12 M CHF
Technology used in webpage:
Nginx Baidu Analytics QuickPacket
Similar Organizations
PanGenetics
PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
More informations about "Kenta Biotech"
Kenta Biotech 2025 Company Profile: Valuation, Investors
Kenta Biotech General Information Description. Provider of monoclonal antibodies for the treatment of hospital infections. The company focuses on providing monoclonal antibodies for โฆSee details»
Kenta Biotech Ltd. - VentureRadar
Kenta Biotech is focusing on the development of innovative, fully human monoclonal antibodies for the treatment of life-threatening hospital infections such as hospital acquired pneumonia. โฆSee details»
Kenta Biotech - LinkedIn
Kenta Biotech is focusing on the discovery and development of innovative, fully human monoclonal antibodies for the treatment of life-threatening hospital infections such as hospital acquired ...See details»
Kenta Biotech AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kenta Biotech AG of Zug, ZUG. Get the latest business insights from Dun & Bradstreet.See details»
Kenta Biotech (Monoclonal Antibody Products and Technologies)
Kenta Biotech (Monoclonal Antibody Products and Technologies) was acquired by Aridis Pharmaceuticals. Data Transparency. Meet our data hygiene team. Discover how our experts โฆSee details»
Kenta Biotech Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Kenta Biotech Ltd including stock price, company news, executives, board members, and contact informationSee details»
Kenta Biotech makes strategic move by relocating to Bio โฆ
About Kenta Biotech Kenta Biotech is a biopharmaceutical company headquartered in Zurich-Schlieren, Switzerland, focusing on the development of innovative fully human monoclonal โฆSee details»
Kenta Biotech AG:Company Profile & Technical โฆ
Kenta Biotech AG is a company that provides Monoclonal antibody, Medicine and more. Kenta Biotech AG is headquartered in Switzerland Zug. Kenta Biotech AG was founded in 2006. โฆSee details»
Kenta Biotech Overview | SignalHire Company Profile
Organization Website: kentabiotech.com : Social Links: Phone Number: 41 58 680 52 52: Kenta Biotech industries Biotech: Kenta Biotech Employees Size 10-50 employees: Specialties: โฆSee details»
Kenta Biotech - Funding, Financials, Valuation & Investors
Kenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections. ... Experience the new Crunchbase, powered by AI . Experience โฆSee details»
Kenta Biotech Ltd - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Organization | Kenta Biotech Ltd - Purdue University
Kenta Biotech Ltd Report issue. For profit Phase 2. Founded: Zug Switzerland ... Organization Overview. First Clinical Trial. 2008 NCT00851435. First Marketed Drug. None First NDA โฆSee details»
Kenta Biotech - Overview, News & Competitors | ZoomInfo.com
Kenta Biotech - Business Information. Business Services · Switzerland · 34 Employees. About Kenta Biotech Kenta Biotech is a biopharmaceutical company headquartered in Zurich โฆSee details»
Kenta Biotech AG - Handelszeitung
Kenta Biotech AG. Über das Unternehmen. präsentiert von. Branche. Durchführung von Forschungen und Entwicklungen. Firmensitz Zug. Rechtsform Aktiengesellschaft.See details»
Kenta Biotech AG - Drug pipelines, Patents, Clinical trials - Synapse
Mar 7, 2025 Kenta Biotech is dedicated to discovering and developing groundbreaking, fully human monoclonal antibodies for the treatment of severe infectious diseases. To achieve this, โฆSee details»
Kenta Biotech Ltd. - BioCentury Company Profiles - BCIQ
May 1, 2014 Kenta Biotech Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Kenta Biotech - Products, Competitors, Financials, Employees ...
Aridis Pharma Picks Up Kenta Biotech's Anti-Infection Products. May 17, 2013. Tweet Aridis Pharmaceuticals is buying Kenta Biotechโs anti-infection treatment products for an undisclosed โฆSee details»
Kenta Biotech - Contacts, Employees, Board Members
Kenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections. ... Experience the new Crunchbase, powered by AI . โฆSee details»
Kenta Biotech AG (Kenta Biotech AG) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ โฆ
Mar 6, 2025 ้กนไธ Kenta Biotech AG ็ธๅ ณ็ๆ็ฎ๏ผๅป่ฏ๏ผ 2010-04-01 · Journal of pharmaceutical and biomedical analysis 3ๅบ · ๅปๅญฆ A comparative characterization of โฆSee details»